ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

NCT00394082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: ABI-007
DRUG: Bevacizumab

Sponsor

Celgene